PPARG and cancer: While it isdifficult at this time to use PPAR-γ ligands at a clinical dose (relativelynontoxic therapeutic approach) as suppressive cancer therapy, we stronglysuggest that further research may confirm PPAR-γ ligands as a novel approach tothe treatment of PC and TC.